Coventry University Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Norwich Research Park Featured PhD Programmes
Engineering and Physical Sciences Research Council Featured PhD Programmes
Cardiff University Featured PhD Programmes
"radiotherapy"×
10 miles

Cancer / Oncology (radiotherapy) PhD Projects, Programs & Scholarships

We have 38 Cancer / Oncology (radiotherapy) PhD Projects, Programs & Scholarships

  • "radiotherapy" ×
  • Cancer / Oncology×
  • clear all
Order by 
Showing 1 to 10 of 38
  (MCRC Non-Clinical) The feasibility, benefits and risks of heart sparing strategies in lung cancer radiotherapy
  Dr G Price, Dr A McWilliam, Dr A Salem
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. Lung cancer is the most common cause of cancer death in the UK. Patients are often frail with multiple co-morbidities, making them unsuitable for surgery.
  Targeting ERK5 to enhance the DNA damage response to radiotherapy and chemotherapy
  Dr K Finegan, Dr C Demonacos
Applications accepted all year round

Funding Type

PhD Type

ERK5 is a signalling protein that enables cells to transduce extracellular signals into responses. It is expressed in all tissues and is up-regulated in tumours.
  (MCRC Clinical - Leeds-Manchester) Multi-parametric MRI as a biomarker in CNS radiotherapy trials
  Prof S Short, Dr Stuart Currie, Dr L Murray, Dr M Merchant
Application Deadline: 1 December 2019

Funding Type

PhD Type

This project will apply advanced MR imaging techniques to the problem of risk estimation in patients undergoing complex CNS radiotherapy interventions.
  (MCRC Clinical) Developing circulating and imaging biomarkers towards personalised radiotherapy in lung cancer
  Prof C Faivre-Finn, Dr G Price, Prof C Dive
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. Approximately a third of Non-Small Cell Lung Cancer cases are locally-advanced (LA-NSCLC) at presentation (~13,000 pts a year in the UK) with the majority being unsuitable for curative surgery.
  Combined functional MRI and super-resolution ultrasound for non-invasive monitoring of tumour blood delivery during breast cancer radiotherapy.
  Prof M Tang, Dr N Somaiah, Dr M Blackledge
Application Deadline: 22 November 2019

Funding Type

PhD Type

Combined super-resolution ultrasound and functional MRI for non-invasive monitoring of tumour blood delivery during breast cancer radiotherapy.
  (MCRC Non-Clinical) Optimising proton radiotherapy for head and neck cancer patients
  Dr A McWilliam, Prof David Thompson, Dr M Lowe
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. Treatment of oropharyngeal cancer with chemo-radiotherapy results in a high incident of acute toxicities. This is particularly important for the increasing proportion of patients who are HPV positive as these are younger patients with a greater chance of survival.
  Precision Medicine DTP - Determining clinically significant early stage lung cancers from image analysis
  Dr W.H. Nailon
Application Deadline: 8 January 2020

Funding Type

PhD Type

Additional Supervisors. Dr Iain Philipps, Dr Duncan Mclaren & Dr Stephen Harrow. Background. Stereotactic Ablative Body Radiotherapy (SABR) is an image guided radiotherapy technique, used to deliver a curative treatment for early stage lung cancer.
  HDAC inhibitors: a potential therapy for breast cancer?
  Dr C Staton, Dr B Corfe
Applications accepted all year round

Funding Type

PhD Type

Radiation resistance, due to hypoxia, remains a major cause of mortality in the treatment of breast cancer.
  (MCRC Non-Clinical) Exploiting ERK5-signalling to modify T-cell behaviour during tumour progression and radiotherapy response: a new immunotherapy approach?
  Dr K Finegan, Dr J Honeychurch, Prof K Williams, Prof T Illidge
Application Deadline: 1 December 2019

Funding Type

PhD Type

Project summary. ERK5 is a signalling protein that enables cells to transduce extracellular signals into responses. It is expressed in all tissues and is up-regulated in tumours.
  MRC DiMeN Doctoral Training Partnership: Activation of Aurora Kinase A by DNA damage – understanding the signalling pathway to improve radiotherapy response
  Dr H Bryant, Prof C Eyers, Prof P Eyers
Application Deadline: 6 January 2020

Funding Type

PhD Type

Radiation is a mainstay of cancer therapy, however radioresistance is a significant challenge in the treatment of locally advanced, recurrent and metastatic cancers.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2019
All rights reserved.